| Negative | HIV-1 | HIV-2 | HIV-1 + HIV-2 dual | Total | ||||
---|---|---|---|---|---|---|---|---|---|
 | Men | Women | Men | Women | Men | Women | Men | Women | All |
Previous HIV result from 1987, 1989, 1990, 1992, 1994 or 1996. | 1,250 | 1,260 | 10 | 12 | 156 | 243 | 5 | 8 | 2,944 |
Total re-identified | 1,247 | 1,259 | 10 | 12 | 156 | 243 | 5 | 8 | 2,940 |
Confusion/age uncertain | 1/0 | 4/0 | 0/0 | 0/0 | 4/1 | 4/1 | 0/0 | 0/0 | 13/2 |
Exit study at age <35. | 37 | 43 | 0 | 0 | 2 | 4 | 0 | 0 | 86 |
Total participating in analysis: | 1,209 | 1,212 | 10 | 12 | 149 | 234 | 5 | 8 | 2,839 |
Seroconvert during follow-up time | 7 | 9 | Â | Â | 2 | 3 | Â | Â | Â |
(status after sero-conversion) | (2 HIV-1, 4 HIV-2 1 HIV-1/2) | (HIV-2) | Â | Â | (HIV-1/2) | (HIV-1/2) | Â | Â | Â |
Moved (%*) | 198 (16.5) | 212 (17.6) | 4 (33.3) | 1 (8.3) | 23 (15.2) | 51(21.3) | 4 (50) | 2 (18.2) | 495 (17.4) |
Died (%*) | 229 (19.1) | 171 (14.2) | 4 (33.3) | 3 (25) | 42 (27.8) | 63 (26.3) | 2 (25) | 3 (27.3) | 517 (18.2) |
Median follow-up time in years | 3.8 | 3.9 | 2.5 | 3.1 | 3.8 | 3.7 | 3.2 | 2.6 | 3.8 |
(range) | (0.0–12.1) | (0.0–12.4) | (0.2–4.3) | (0.4–3.8) | (0.1–11.6) | (0.1–12.0) | (0.3–5.9) | (0.6,4.5) | (0.0–12.4) |
Total follow-up time, years | 5084 | 5398 | 26.9 | 33.6 | 648 | 1039 | 23.7 | 29.7 | 12283 |
Mortality rate/1000 pyo | 45.0 | 31.7 | 149 | 89.3 | 64.8 | 60.6 | 84.3 | 101 | 42.1 |
(95% CI†) | (39.5,51.3) | (27.3, 36.8) | (55.9, 397) | (28.8, 278) | (47.9, 87.7) | (47.3,77.6) | (21.1, 337) | (32.6, 313) | (38.6, 45.9) |